We are live on
!
Find out more
TC
Tavio Capital Portfolio holdings
AUM
$75.4M
1-Year Est. Return
27.99%
This Fund
S&P 500
This Quarter
Est. Return
-6.89%
1 Year Est. Return
+27.99%
3 Year Est. Return
+81.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$69.3M
AUM Growth
-$202M
(-74%)
Cap. Flow
-$187M
Cap. Flow
% of AUM
-269.85%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
–
Reduced
6
Closed
6
Top Buys
No buys this quarter
Top Sells
| 1 |
Labcorp
LH
|
+$29.9M |
| 2 |
Zimmer Biomet
ZBH
|
+$29.5M |
| 3 |
HCA Healthcare
HCA
|
+$28M |
| 4 |
Humana
HUM
|
+$25M |
| 5 |
Centene
CNC
|
+$16.9M |
Sector Composition
| 1 | Healthcare | 100% |
Similar funds
PC
EGPO
AIS
MCMT
NBG
FC
SCM
MVM
Tavio Capital's Q1 2020 Portfolio in Review
As of Q1 2020, Tavio Capital held 12 positions worth $69.3M, down 74% from $271M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tavio Capital withdrew a net $187M in Q1 2020, closing 6 positions and reducing 6 holdings. Its most notable exit was Labcorp, an estimated $29.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 97% a quarter earlier.
- Tavio Capital's biggest Q1 2020 reduction was Zimmer Biomet, cutting an estimated $29.5M.
- Tavio Capital fully exited Labcorp in Q1 2020, selling an estimated $29.9M.
- Tavio Capital's ten largest holdings make up 100% of its $69.3M portfolio in Q1 2020.
- Tavio Capital opened 0 new positions and closed 6 in Q1 2020.
- Tavio Capital's portfolio value fell 74% quarter-over-quarter to $69.3M.
Based on Tavio Capital's 13F filing for Q1 2020, filed 14 May 2020.